💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Cogentix Medical, Inc. (CGNT)
« Back to company indexCGNT Chatter Timeline
Stock Ticker for CGNT
Most Active Tweeters for CGNT
| User | Tweets |
|---|---|
| @Tickeron | 2 |
| @LeeSinTrade1 | 2 |
| @ShortAlgoTrades | 1 |
Recent Tweets for CGNT
 |
@ShortAlgoTrades $CGNT Awaiting Buy Signal. Algorithmic Trading by https://t.co/jpmUt7BvVp https://t.co/TAlFg0mj7L October 20th 2021, 1:10pm |
 |
@LeeSinTrade1 $CGNT Waiting for Buy signal on CGNT with https://t.co/yV6BCXxMw6 https://t.co/xqfjgL9Vdu October 19th 2021, 10:10pm |
 |
@Tickeron $CGNT's price moved below its 50-day Moving Average on September 20, 2021. View odds for this and other indicators:… https://t.co/Ic0J91Txek October 19th 2021, 6:10pm |
|
@LeeSinTrade1 $CGNT Waiting for Short signal on CGNT with https://t.co/yV6BCXxMw6 https://t.co/oxnJBI6etv October 17th 2021, 12:10am |
|
@Tickeron $CGNT in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/EhOygqFBL0 October 14th 2021, 2:10pm |
 |
@AlertTrade REVERSALtoUP: $CGNT Cognyte Software Ltd. Ordinary Shares ? TradeIdeas via ? https://t.co/VS8RO1bzXJ October 6th 2021, 6:10pm |
 |
@LargeVoidBot Daily Reversal (15:47): $CGNT Last: 20.59; pHigh: 20.59; rVol: 0.902; pClose: 20.29; LOD: 20.0300; Perf: 1.5% October 5th 2021, 7:10pm |
|
@LeeSinTrade1 $CGNT Waiting for Buy signal on CGNT with https://t.co/BkbG15Qkmu https://t.co/n7tPLctuue October 4th 2021, 8:10pm |
 |
@kwhenfinance Cognyte Software Ltd Shares Fall 3.9% Below Previous 52-Week Low - Market Mover https://t.co/S3s9U25Z71 $CGNT #stockmarket #kwhenfinance October 4th 2021, 12:10pm |
 |
@smijotrading $CGNT ready for a nice comeback … get in below 20.75… Join our premium room for more tips and alerts… we post before the POP! October 4th 2021, 1:10am |
|
@Tickeron $CGNT's price moved below its 50-day Moving Average on September 20, 2021. View odds for this and other indicators:… https://t.co/w3hmQ5mhu1 October 3rd 2021, 3:10am |
|
@ShortAlgoTrades $CGNT Waiting for Buy signal on CGNT with https://t.co/sjROqPnc9P. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/BKUNo7xjTn October 2nd 2021, 9:10pm |
|
@ShortAlgoTrades $CGNT Waiting for Buy signal on CGNT with https://t.co/sjROqPnc9P https://t.co/9neTbFWotO October 2nd 2021, 8:10pm |
 |
@LeviTrade2 $CGNT Waiting for Buy signal on CGNT with https://t.co/gd5deldXML https://t.co/wPxS0xxQnP October 2nd 2021, 8:10pm |
 |
@69NiceBot69 RT @LargeVoidBot: Daily Reversal (09:36): $CGNT Last: 20.87; pHigh: 20.69; rVol: 2.849; pClose: 20.55; LOD: 20.8700; Perf: 1.6% October 1st 2021, 1:10pm |
|
@LargeVoidBot Daily Reversal (09:36): $CGNT Last: 20.87; pHigh: 20.69; rVol: 2.849; pClose: 20.55; LOD: 20.8700; Perf: 1.6% October 1st 2021, 1:10pm |
|
@LeeSinTrade1 $CGNT Waiting for Buy signal on CGNT with https://t.co/yV6BCXxMw6 https://t.co/X6dKyuiHuT October 1st 2021, 12:10am |
 |
@OptionHunt Ticker $CGNT Unusual Volume Detected: 9.68% over average September 30th 2021, 2:09pm |
|
@ShortAlgoTrades $CGNT Awaiting Buy Signal. Algo Trading at https://t.co/jpmUt7BvVp! https://t.co/UExABYHNFZ September 30th 2021, 10:09am |
|
@LeeSinTrade1 $CGNT Waiting for Buy signal on CGNT with https://t.co/yV6BCXxMw6 https://t.co/4xC0afZe7b September 29th 2021, 10:09pm |
|
@kwhenfinance Cognyte Software Ltd Shares Near 52-Week Low - Market Mover https://t.co/kLRNyUCAF8 $CGNT #stockmarket #kwhenfinance September 29th 2021, 4:09pm |
|
@LargeVoidBot 09:54 New 52wk Lows: $CGNT September 28th 2021, 1:09pm |
|
@Tickeron Cognyte Software Ltd to report earnings on November 06, 2018. Earnings per share (EPS) estimate: $-0.01 $CGNT… https://t.co/lwpa3AbsDJ September 28th 2021, 7:09am |
|
@ShortAlgoTrades $CGNT Waiting for a BUY signal on CGNT with https://t.co/QwgkByhUfo. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/Db1FGtOhtY September 27th 2021, 11:09pm |
|
@Tickeron $CGNT's 10-day Moving Average crossed below its 50-day Moving Average on September 22, 2021. View odds for this and… https://t.co/eWvuWl1B64 September 26th 2021, 8:09pm |
 |
@MarketChmln $CGNT option volume was 13X normal on Friday with 2,767 contracts. Call volume was 22% and put volume was 78%. https://t.co/X0Bx1hmlYN September 25th 2021, 6:09pm |
|
@Tickeron $CGNT's price moved below its 50-day Moving Average on September 20, 2021. View odds for this and other indicators:… https://t.co/QMxF3iMAxL September 25th 2021, 1:09am |
 |
@StckPro $CGNT NEW ARTICLE : This week's under the radar earnings reports https://t.co/TW5EKLYfYS Get all the latest $CGNT r… https://t.co/WIYpFZoRbO September 24th 2021, 8:09pm |
|
@ShortAlgoTrades $CGNT Waiting for buy signal on CGNT. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/oouTX63tvS September 24th 2021, 2:09pm |
|
@LargeVoidBot 10:11 New 52wk Lows: $CGNT September 24th 2021, 2:09pm |
|
@ShortAlgoTrades $CGNT Waiting for a buy signal on CGNT with https://t.co/QwgkByhUfo. Learn more at https://t.co/ZzhEUJ8ooJ https://t.co/85QTmPFNik September 23rd 2021, 8:09pm |
|
@ShortAlgoTrades $CGNT waiting for buy signal on CGNT. Learn more at https://t.co/ZzhEUJpZgh https://t.co/ziRkLi5rBR September 22nd 2021, 7:09pm |
|
@LargeVoidBot 15:06 New 52wk Lows: $CGNT September 22nd 2021, 7:09pm |
 |
@SeekingAlpha $CGNT - Is Cognyte Software Stock A Buy Or Sell After Q2 Earnings? Looks Interesting On The Dip.… https://t.co/W1O4eVaWRR September 21st 2021, 9:09pm |
 |
@starcevic_alex EARNING BEFORE OPEN 9/20/21 $CGNT $AMBO September 21st 2021, 7:09pm |
 |
@shortablestocks $CGNT is short sale restricted for 2021-09-21. https://t.co/suOazd0TEM September 21st 2021, 1:09pm |
 |
@SwingTradeBot $CGNT technical alerts: Slingshot Bullish, Wide Range Bar, Fell Below 50 DMA, MACD Bearish Signal... https://t.co/glNp39xjir September 21st 2021, 12:09pm |
 |
@ResearchPool $CGNT #Cognyte Software Ltd. Delivers Good Results But Lumpy Guidance in 2H Concerns Street; PT to $32: [...]… https://t.co/4TThlTLbhQ September 21st 2021, 10:09am |
 |
@newsfilterio Cognyte Announces Second Quarter Results $CGNT https://t.co/fQs5u26WdA September 21st 2021, 5:09am |
 |
@15minofPham Mon (9/20/21) earnings +/- % from the opening 30-min high (Min $5 & Vol 750K, Opt Min Vol 250 in any strike): $CGNT https://t.co/57h8ADryoJ September 21st 2021, 3:09am |
|
@newsfilterio Cognyte Software Shares Drop On Weak Q3 Outlook $CGNT https://t.co/dYMda2jSqm September 21st 2021, 1:09am |
|
@ShortAlgoTrades $CGNT Awaiting Buy signal. Stock Trading Ideas by UltraAlgo. https://t.co/IysEm0so5p September 20th 2021, 9:09pm |
|
@Tickeron $CGNT enters an Uptrend because Momentum Indicator exceeded the 0 level on September 10, 2021. View odds for this a… https://t.co/SuTc5N616v September 20th 2021, 4:09pm |
 |
@rndmtwitaccount @StockoTrading Bought some $CGNT. Like the company, owned for few years (pre split). Cash flow positive SW company,… https://t.co/vHzViijp51 September 20th 2021, 4:09pm |
|
@StckPro $CGNT NEW ARTICLE : Cognyte Software Ltd. (CGNT) CEO Elad Sharon on Q2 2022 Results - Earnings Call Transcript… https://t.co/VLjWfgUiWY September 20th 2021, 4:09pm |
 |
@BiafraBirth RT @SeekingAlpha: $CGNT - Cognyte Software Ltd. (CGNT) CEO Elad Sharon on Q2 2022 Results - Earnings Call Transcript. https://t.co/kJWhyq0h… September 20th 2021, 4:09pm |
|
@SeekingAlpha $CGNT - Cognyte Software Ltd. (CGNT) CEO Elad Sharon on Q2 2022 Results - Earnings Call Transcript.… https://t.co/nfZJyXOWA6 September 20th 2021, 4:09pm |
|
@MarketChmln $CGNT share price decreases -13.3%. See recent news release. https://t.co/mRiwvxLYDg September 20th 2021, 3:09pm |
|
@StckPro $CGNT NEW ARTICLE : Cognyte Software plummets despite raising profitability guidance for FY22… https://t.co/U1LVVavKH3 September 20th 2021, 2:09pm |
|
@newsfilterio Cognyte Software plummets despite raising profitability guidance for FY22 $CGNT https://t.co/MZsuVr68mS September 20th 2021, 2:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?